Cadila Pharmaceuticals, one of India’s top global drug manufacturers, has officially entered the Asia Book of Records. The ...

Lonza and Asimov have announced a strategic collaboration aimed at advancing lentiviral vector (LVV) manufacturing for ...

Jubilant Draximage Inc. is investing CAD 94.5 million to modernize and expand its facility in Kirkland, Québec. The expansion ...

Nearly 25% of all colon cancers are diagnosed at stage III, and almost one in three patients with stage III colon cancer ...

His remarks underscored the need to strengthen India's capabilities in drug development, biosimilars and pharmaceutical ...

The country’s population aged 60 years and above is projected to rise from around 153 million in 2022 to approximately 347 ...

Global pharma major Lupin Limited announced that it has received approval from the United States Food and Drug Administration ...

BMS said the safety profile of ZENBEXUS in combination with standard therapies was consistent with previously reported ...

The supplemental New Drug Application (sNDA) was based on the positive Phase III FIND-CKD study results ...

The approval by China’s National Medical Products Administration (NMPA) covers Cekol CMC-Na, a plant-based carboxymethyl cellulose (CMC) excipient used to bind, thicken and stabilize pharmaceutical ...

Novartis is set to present 46 abstracts from its multiple sclerosis (MS) portfolio at MSToronto2026, the 10th Joint ...

The findings extend evidence from the LATITUDE study, which showed CAB + RPV LA was superior to daily oral therapy at ...